Key Takeaways from the 2022 American Society of Hematology (ASH) Conference

Originally published in the Winter 2023 edition of Myeloma Today, a quarterly journal from the IMF, this article provides an overview of the top abstracts of interest presented during myeloma sessions at the 64th Annual Meeting & Exposition of the American Society of Hematology (ASH) in December 2022. At ASH, more than 1,000 of the abstracts presented were related to myeloma. IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Duirie reports on patterns and insights leared about development in myeloma treatments and diagnosis. https://www.myeloma.org/blog/key-takeaways-ash-2022